Cargando…
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases
Eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) are driven by persistently high eosinophil numbers, causing damage to tissues and organs. As rare diseases, they are often underappreciated by healthcare professionals. Using a social listening analysis, we col...
Autores principales: | Strobel, Mary Jo, Alves, Debbie, Roufosse, Florence, Antoun, Zeina, Kwon, Namhee, Baylis, Lee, Wechsler, Michael E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756368/ https://www.ncbi.nlm.nih.gov/pubmed/36530646 http://dx.doi.org/10.1177/23743735221143953 |
Ejemplares similares
-
Eosinophils and eosinophilic immune dysfunction in health and disease
por: Jackson, David J., et al.
Publicado: (2022) -
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases
por: Pavord, Ian D., et al.
Publicado: (2021) -
Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
por: Roufosse, Florence
Publicado: (2018) -
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
por: Terrier, Benjamin, et al.
Publicado: (2023) -
Editorial: Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation
por: Roufosse, Florence E., et al.
Publicado: (2018)